My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 63

    1.

    Clopidogrel resistance "Live" - the risk of stent thrombosis should be evaluated before procedures.

    Motovska Z, Widimsky P, Marinov I, Petr R, Hajkova J, Kvasnicka J; the PRAGUE-8 study Investigators.

    Thromb J. 2009 May 19;7(1):6.PMID: 19454028 [PubMed - as supplied by publisher]Free PMC ArticleFree textRelated citations

    2.

    Review of prasugrel for the secondary prevention of atherothrombosis.

    Spinler SA, Rees C.

    J Manag Care Pharm. 2009 Jun;15(5):383-95. Review.PMID: 19496635 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    4.

    Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes.

    Baker WL, White CM.

    Am J Cardiovasc Drugs. 2009;9(4):213-29. doi: 10.2165/1131209-000000000-00000. Review.PMID: 19655817 [PubMed - indexed for MEDLINE]Related citations

    5.

    Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

    Lincoff AM, Steinhubl SR, Manoukian SV, Chew D, Pollack CV Jr, Feit F, Ware JH, Bertrand ME, Ohman EM, Desmet W, Cox DA, Mehran R, Stone GW; Acute Catheterization and Urgent Intervention Triage strategY of Trial Investigators.

    JACC Cardiovasc Interv. 2008 Dec;1(6):639-48.PMID: 19463378 [PubMed - indexed for MEDLINE]Related citations

    6.

    The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy.

    Saw J, Densem C, Walsh S, Jokhi P, Starovoytov A, Fox R, Wong G, Buller C, Ricci D, Mancini GB, Fung A.

    JACC Cardiovasc Interv. 2008 Dec;1(6):654-9.PMID: 19463380 [PubMed - indexed for MEDLINE]Related citations

    7.

    A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.

    Han YL, Wang B, Li Y, Xu K, Wang SL, Jing QM, Wang ZL, Wang DM, Ma YY, Wang G.

    Chin Med J (Engl). 2009 Apr 5;122(7):793-7.PMID: 19493391 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    9.

    Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting.

    Campo G, Valgimigli M, Carrescia C, Carletti R, Ferrari R.

    Clin Appl Thromb Hemost. 2009 Jun 10. [Epub ahead of print]PMID: 19520678 [PubMed - as supplied by publisher]Related citations

    10.

    Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.

    Cuisset T, Frere C, Quilici J, Gaborit B, Castelli C, Poyet R, Bali L, Morange PE, Alessi MC, Bonnet JL.

    Am J Cardiol. 2009 Oct 15;104(8):1078-82.PMID: 19801028 [PubMed - indexed for MEDLINE]Related citations

    11.

    Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).

    Tanzilli G, Greco C, Pelliccia F, Pasceri V, Barillà F, Paravati V, Pannitteri G, Gaudio C, Mangieri E.

    Am J Cardiol. 2009 Nov 15;104(10):1357-61. Epub 2009 Sep 26.PMID: 19892050 [PubMed - indexed for MEDLINE]Related citations

    12.

    The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial.

    Gladding P, Webster M, Zeng I, Farrell H, Stewart J, Ruygrok P, Ormiston J, El-Jack S, Armstrong G, Kay P, Scott D, Gunes A, Dahl ML.

    JACC Cardiovasc Interv. 2008 Dec;1(6):620-7.PMID: 19463375 [PubMed - indexed for MEDLINE]Related citations

    13.

    The antiplatelet effect of higher loading and maintenance dose regimens of clopidogrel: the PRINC (Plavix Response in Coronary Intervention) trial.

    Gladding P, Webster M, Zeng I, Farrell H, Stewart J, Ruygrok P, Ormiston J, El-Jack S, Armstrong G, Kay P, Scott D, Gunes A, Dahl ML.

    JACC Cardiovasc Interv. 2008 Dec;1(6):612-9.PMID: 19463374 [PubMed - indexed for MEDLINE]Related citations

    14.

    Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.

    Dangas G, Mehran R, Guagliumi G, Caixeta A, Witzenbichler B, Aoki J, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Rabbani LE, Parise H, Stone GW; HORIZONS-AMI Trial Investigators.

    J Am Coll Cardiol. 2009 Oct 6;54(15):1438-46.PMID: 19796737 [PubMed - indexed for MEDLINE]Related citations

    15.

    Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.

    Pinto Slottow TL, Bonello L, Gavini R, Beauzile P, Sushinsky SJ, Scheinowitz M, Kaneshige K, Xue Z, Torguson R, Tantry U, Pichard AD, Satler LF, Suddath WO, Kent K, Gurbel P, Waksman R.

    Am J Cardiol. 2009 Aug 15;104(4):525-30. Epub 2009 Jun 24.PMID: 19660606 [PubMed - indexed for MEDLINE]Related citations

    16.

    Acute and subacute stent thrombosis in a patient with clopidogrel resistance: a case report.

    Kim SS, Jeong MH, Kim HK, Bae SY, Ryu KH, Cho KH, Kim MC, Park KH, Sim DS, Hong YJ, Kim JH, Ahn Y, Kang JC.

    Korean Circ J. 2009 Oct;39(10):434-8. Epub 2009 Oct 28.PMID: 19949590 [PubMed - in process]Free PMC ArticleFree textRelated citations

    17.

    Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population.

    Wiederkehr D, Ogbonnaya A, Casciano R, Makenbaeva D, Mozaffari E, Corbelli J.

    Curr Med Res Opin. 2009 Sep;25(9):2327-34.PMID: 19635046 [PubMed - indexed for MEDLINE]Related citations

    18.

    Week-long high-maintenance dose clopidogrel regimen achieves better platelet aggregation inhibition than a standard loading dose before percutaneous coronary intervention: results of a double-blind, randomized clinical trial.

    Nguyen TA, Lordkipanidzé M, Diodati JG, Palisaitis DA, Schampaert E, Turgeon J, Pharand C.

    J Interv Cardiol. 2009 Aug;22(4):368-77.PMID: 19689661 [PubMed - in process]Related citations

    19.

    High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial.

    Motovska Z, Widimsky P, Kvasnicka J, Petr R, Bilkova D, Hajkova J, Marinov I, Simek S, Kala P; PRAGUE-8 study investigators.

    Blood Coagul Fibrinolysis. 2009 Jun;20(4):257-62.PMID: 19530321 [PubMed - indexed for MEDLINE]Related citations

    20.

    Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: a comparison of two strategies.

    Davlouros PA, Arseniou A, Hahalis G, Chiladakis J, Mazarakis A, Damelou A, Karakantza M, Paliogianni F, Karogiannis N, Alexopoulos D.

    Am Heart J. 2009 Oct;158(4):585-91.PMID: 19781418 [PubMed - indexed for MEDLINE]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk